IMPRIMIS PHARMACEUTICALS INC (IMMY)
Institutional ownership reported to the SEC as of Q1 2020, across 6 quarters.
1
Reporting holders
$9.6M
Reported value
0.0%
Held as options
+0
Holder change
Options share is the part of reported value carried in derivative lines rather than shares. A high figure means institutions are expressing a view on this security without owning much of it.
Holders
| Filer | Value | Shares | Their book | Held | Change |
|---|---|---|---|---|---|
| Opaleye Management Inc. | $9.6M | 2,500,000 | 2.53% | 6q | +6.8%+$611.2K |
Quarter by quarter
Coverage begins with the quarter ending 2018-12-31. Earlier filings exist only as occasional late amendments, too sparse to describe a market, so they are not shown.
| Quarter | Holders | Value | Shares | New | Added | Trimmed | Options |
|---|---|---|---|---|---|---|---|
| Q1 2020 | 1 | $9.6M | 2,500,000 | 0 | 1 | 0 | 0.0% |
| Q4 2019 | 1 | $18.2M | 2,340,000 | 0 | 0 | 1 | 0.0% |
| Q3 2019 | 1 | $13.3M | 2,370,000 | 0 | 1 | 0 | 0.0% |
| Q2 2019 | 1 | $19.2M | 2,210,000 | 0 | 1 | 0 | 0.0% |
| Q1 2019 | 1 | $9.0M | 1,800,000 | 0 | 1 | 0 | 0.0% |
| Q4 2018 | 42 | $31.1M | 5,471,381 | 3 | 2 | 0 | 0.0% |